Progress in clinical trials of cell transplantation for the treatment of spinal cord injury: how many questions remain unanswered?Xu-Chang Hu, Yu-Bao Lu, Yong-Na Yang, Xue-Wen Kang, Yong-Gang Wang, Bing Ma, Shuai Xing405-413
Postnatal therapeutic approaches in genetic neurodevelopmental disordersGilad Levy, Boaz Barak414-422
Regulation of neuroimmune processes by damage- and resolution-associated molecular patternsAndis Klegeris423-429
Neonatal opioid exposure: public health crisis and novel neuroinflammatory diseaseVikram Vasan, Yuma Kitase, Jessie C. Newville, Shenandoah Robinson, Gwendolyn Gerner, V. Joanna Burto, Lauren L. Jantzie430-432
Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical strokeHilda Martínez-Coria, Isabel Arrieta-Cruz, María-Esther Cruz, Héctor E. López-Valdés433-439
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitationsBridget Martinez, Philip V. Peplow440-447
Microglial activation and adult neurogenesis after brain strokeIjair R.C. dos Santos, Michelle Nerissa C. Dias, Walace Gomes-Leal456-459
The therapeutic potential of targeting exchange protein directly activated by cyclic adenosine 3′,5′-monophosphate (Epac) for central nervous system traumaAlba Guijarro-Belmar, Dominik Mateusz Domanski, Xuenong Bo, Derryck Shewan, Wenlong Huang460-469
Role of vitamin B12 deficiency in ischemic stroke risk and outcomeGyllian B. Yahn, Jamie E. Abato, Nafisa M. Jadavji470-474
